244 related articles for article (PubMed ID: 20646773)
1. Preservation of basal AcSDKP attenuates carbon tetrachloride-induced fibrosis in the rat liver.
Chen YW; Liu BW; Zhang YJ; Chen YW; Dong GF; Ding XD; Xu LM; Pat B; Fan JG; Li DG
J Hepatol; 2010 Sep; 53(3):528-36. PubMed ID: 20646773
[TBL] [Abstract][Full Text] [Related]
2. Antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline on bile duct ligation induced liver fibrosis in rats.
Zhang L; Xu LM; Chen YW; Ni QW; Zhou M; Qu CY; Zhang Y
World J Gastroenterol; 2012 Oct; 18(37):5283-8. PubMed ID: 23066324
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
[TBL] [Abstract][Full Text] [Related]
4. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats.
Li J; Liu P; Zhang R; Cao L; Qian H; Liao J; Xu W; Wu M; Yin Z
J Ethnopharmacol; 2011 Sep; 137(1):714-23. PubMed ID: 21726622
[TBL] [Abstract][Full Text] [Related]
5. All-trans-retinoic acid ameliorates carbon tetrachloride-induced liver fibrosis in mice through modulating cytokine production.
Hisamori S; Tabata C; Kadokawa Y; Okoshi K; Tabata R; Mori A; Nagayama S; Watanabe G; Kubo H; Sakai Y
Liver Int; 2008 Nov; 28(9):1217-25. PubMed ID: 18397230
[TBL] [Abstract][Full Text] [Related]
6. [Effect of N-acetyl-seryl-aspartyl-lysyl-proline on regulation of expression of ras-raf-ERK1/2 signal transduction pathway in lung of rats with silicosis].
Tian JR; Yang F; Li DD; Zhang LJ; Wei ZQ; Feng HL; Li ZG; Wang RM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2010 Oct; 28(10):760-5. PubMed ID: 21126429
[TBL] [Abstract][Full Text] [Related]
7. N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) mitigates the liver fibrosis via WTAP/m
Wei A; Zhao F; Hao A; Liu B; Liu Z
Gene; 2022 Mar; 813():146125. PubMed ID: 34921949
[TBL] [Abstract][Full Text] [Related]
8. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
[TBL] [Abstract][Full Text] [Related]
9. Hydroxysafflor yellow A attenuates carbon tetrachloride-induced hepatic fibrosis in rats by inhibiting ERK5 signaling.
Zhang YB; Dong HY; Zhao XM; Fan L; Zou Y; Zhang C; Li G; Liu JC; Niu YC
Am J Chin Med; 2012; 40(3):481-94. PubMed ID: 22745065
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin decreases carbon tetrachloride-induced hepatic fibrosis by inhibiting transforming growth factor-beta.
Park SY; Lee JY; Tak WY; Kweon YO; Lee MS
Chin Med J (Engl); 2012 Sep; 125(17):3098-103. PubMed ID: 22932188
[TBL] [Abstract][Full Text] [Related]
11. Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model.
Shim SG; Jun DW; Kim EK; Saeed WK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
J Gastroenterol Hepatol; 2013 Dec; 28(12):1877-84. PubMed ID: 23808892
[TBL] [Abstract][Full Text] [Related]
12. [Effects of nuclear factor kappaB and transforming growth factor beta1 in the anti-liver fibrosis process using Ginkgo biloba extract].
Liu SQ; Yu JP; He L; Yu HG; Luo HS
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):903-7. PubMed ID: 16381635
[TBL] [Abstract][Full Text] [Related]
13. Preventive effects of a fractioned polysaccharide from a traditional Chinese herbal medical formula (Yu Ping Feng San) on carbon tetrachloride-induced hepatic fibrosis.
Wang JJ; Li J; Shi L; Lv XW; Cheng WM; Chen YY
J Pharm Pharmacol; 2010 Jul; 62(7):935-42. PubMed ID: 20636883
[TBL] [Abstract][Full Text] [Related]
14. Hsian-tsao (Mesona procumbens Heml.) prevents against rat liver fibrosis induced by CCl(4) via inhibition of hepatic stellate cells activation.
Shyu MH; Kao TC; Yen GC
Food Chem Toxicol; 2008 Dec; 46(12):3707-13. PubMed ID: 18929613
[TBL] [Abstract][Full Text] [Related]
15. Taurine inhibits oxidative damage and prevents fibrosis in carbon tetrachloride-induced hepatic fibrosis.
Miyazaki T; Karube M; Matsuzaki Y; Ikegami T; Doy M; Tanaka N; Bouscarel B
J Hepatol; 2005 Jul; 43(1):117-25. PubMed ID: 15893842
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin attenuates hepatocellular damage and fibrosis in rats with chronic liver injury.
Sancho-Bru P; Bataller R; Fernandez-Varo G; Moreno M; Ramalho LN; Colmenero J; Marí M; Clària J; Jiménez W; Arroyo V; Brenner DA; Ginès P
Gastroenterology; 2007 Dec; 133(6):2019-28. PubMed ID: 18054572
[TBL] [Abstract][Full Text] [Related]
17. Effects and mechanisms of extract from Paeonia lactiflora and Astragalus membranaceus on liver fibrosis induced by carbon tetrachloride in rats.
Sun WY; Wei W; Wu L; Gui SY; Wang H
J Ethnopharmacol; 2007 Jul; 112(3):514-23. PubMed ID: 17574357
[TBL] [Abstract][Full Text] [Related]
18. The antifibrotic effect of TGF-beta1 siRNAs in murine model of liver cirrhosis.
Kim KH; Kim HC; Hwang MY; Oh HK; Lee TS; Chang YC; Song HJ; Won NH; Park KK
Biochem Biophys Res Commun; 2006 May; 343(4):1072-8. PubMed ID: 16579972
[TBL] [Abstract][Full Text] [Related]
19. Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats.
Xu W; Song S; Huang Y; Gong Z
J Gastroenterol Hepatol; 2006 Aug; 21(8):1250-6. PubMed ID: 16872305
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo antifibrotic effects of rosmarinic acid on experimental liver fibrosis.
Li GS; Jiang WL; Tian JW; Qu GW; Zhu HB; Fu FH
Phytomedicine; 2010 Mar; 17(3-4):282-8. PubMed ID: 19524418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
